基于風險與責任，促進中國兒童合理用藥的思考_《中國循證醫學雜志》

作者：

張伶俐 ,  李幼平 ¹

1. 四川大學華西第二醫院藥劑科（成都?610041）；2. 四川大學華西醫院中國循證醫學中心（成都?610041）;

關鍵詞：

合理用藥兒童

DOI：

10.7507/1672-2531.20110164

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

引用本文： 張伶俐,李幼平. 基于風險與責任，促進中國兒童合理用藥的思考. 中國循證醫學雜志, 2011, 11(9): 983-984. doi: 10.7507/1672-2531.20110164 復制

1.	World Health Organization. Rational use of medicines.2011. Available at: http://www.who.int/medicines/ areas/rational_use/en/.
2.	World Health Organization. World Health Statistics 2010 Part Ⅱ Global Health Indicators. 2010. Available at: http://www.swpho.nhs.uk/resource/item.aspx?RID=78141.
3.	World Health Organization. The global burden of disease 2004 update. 2004. Available at: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/.
4.	Crowley E, Williams R, Cousins D. Medication errors in children: a descriptive summary of medication error reports submitted to the United States Pharmacopeia. Curr Ther Res, 2001, 62(9): 627-640.
5.	Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr, 2005, 164(9): 552-558.
6.	Fang S, Shen BY, Jiang HB. The situation and suggestions of the pediatric drug production and usage in China. Chin Pharma Affairs, 1995, 9(3): 155.
7.	曾力楠, 張伶俐. 兒科藥物臨床試驗的發展歷史及研究現狀. 兒科藥學雜志, 2010, 16(2): 4-7.
8.	中華人民共和國衛生部. 2010中國衛生統計年鑒. 2010. Available at: http://www.moh.gov.cn/publicfiles/business /htmlfiles/zwgkzt/ptjnj/.
9.	秦立忠. 關于小兒劑量這算法. 中國醫院藥學雜志, 1983, 3(3): 27-28.
10.	Department of Health and Human services, Food and Drug Administration. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients. Final Rule: 21 CFR Parts 201, 312, 314, 601. Docket No. 97N-0165.
11.	A European Clinical Trials Registry for Children. Paediatric and Perinatal Drug Therapy, 2003, 5(3): 98-100.
12.	World Health Organization. Medicines: essential medicines, Fact Sheet No.325, Media Centre. 2010. Available at: http://www.who.int/mediacentre/factsheets/fs325/zh/.
13.	張伶俐, 張川, 梁毅, 等. 我國2009版基本藥物目錄（基層）與WHO2010版兒童基本藥物示范目錄比較分析. 中國循證醫學雜志, 2010, 10(9): 1027-1036.
14.	王德志, 海沙爾江·吾守爾, 韓容.《WHO示范處方集》對醫療機構處方集編寫的啟示. 藥品評價, 2010, 7(8): 17-21.
15.	World Health Organization. WHO Model Formulary for Children. Geneva, Switzerland: WHO Press. 2010.
16.	中華人民共和國衛生部. 衛生部發布《中國國家處方集（化學藥品與生物制品卷）（2010年版）》. 2010. Available at: http://www.moh.gov.cn/publicfiles /business/htmlfiles/mohyzs/s3586/201002/45908.htm.
17.	張伶俐, 李幼平, 張川, 等. 中國兒童臨床指南現狀分析及循證臨床指南評價. 中國循證醫學雜志, 2011, 11(9): 991-999.
18.	Ghaleb MA, Barber N, Franklin BD, et al. Systematic Review of medication errors in pediatric patients. Ann Pharmacther, 2006, 40(10): 1766-1776.
19.	韓璐, 蘭瑛, 張伶俐, 等. 7例汶川地震擠壓綜合征患兒用藥分析. 中國循證醫學雜志, 2008, 8(9): 710-712.
20.	韓璐, 曾力楠, 張伶俐, 等. 329例汶川地震婦女兒童傷病員藥物利用分析. 中國循證醫學雜志, 2009, 9(3): 265-272.

1. World Health Organization. Rational use of medicines.2011. Available at: http://www.who.int/medicines/ areas/rational_use/en/.
2. World Health Organization. World Health Statistics 2010 Part Ⅱ Global Health Indicators. 2010. Available at: http://www.swpho.nhs.uk/resource/item.aspx?RID=78141.
3. World Health Organization. The global burden of disease 2004 update. 2004. Available at: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/.
4. Crowley E, Williams R, Cousins D. Medication errors in children: a descriptive summary of medication error reports submitted to the United States Pharmacopeia. Curr Ther Res, 2001, 62(9): 627-640.
5. Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr, 2005, 164(9): 552-558.
6. Fang S, Shen BY, Jiang HB. The situation and suggestions of the pediatric drug production and usage in China. Chin Pharma Affairs, 1995, 9(3): 155.
7. 曾力楠, 張伶俐. 兒科藥物臨床試驗的發展歷史及研究現狀. 兒科藥學雜志, 2010, 16(2): 4-7.
8. 中華人民共和國衛生部. 2010中國衛生統計年鑒. 2010. Available at: http://www.moh.gov.cn/publicfiles/business /htmlfiles/zwgkzt/ptjnj/.
9. 秦立忠. 關于小兒劑量這算法. 中國醫院藥學雜志, 1983, 3(3): 27-28.
10. Department of Health and Human services, Food and Drug Administration. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients. Final Rule: 21 CFR Parts 201, 312, 314, 601. Docket No. 97N-0165.
11. A European Clinical Trials Registry for Children. Paediatric and Perinatal Drug Therapy, 2003, 5(3): 98-100.
12. World Health Organization. Medicines: essential medicines, Fact Sheet No.325, Media Centre. 2010. Available at: http://www.who.int/mediacentre/factsheets/fs325/zh/.
13. 張伶俐, 張川, 梁毅, 等. 我國2009版基本藥物目錄（基層）與WHO2010版兒童基本藥物示范目錄比較分析. 中國循證醫學雜志, 2010, 10(9): 1027-1036.
14. 王德志, 海沙爾江·吾守爾, 韓容.《WHO示范處方集》對醫療機構處方集編寫的啟示. 藥品評價, 2010, 7(8): 17-21.
15. World Health Organization. WHO Model Formulary for Children. Geneva, Switzerland: WHO Press. 2010.
16. 中華人民共和國衛生部. 衛生部發布《中國國家處方集（化學藥品與生物制品卷）（2010年版）》. 2010. Available at: http://www.moh.gov.cn/publicfiles /business/htmlfiles/mohyzs/s3586/201002/45908.htm.
17. 張伶俐, 李幼平, 張川, 等. 中國兒童臨床指南現狀分析及循證臨床指南評價. 中國循證醫學雜志, 2011, 11(9): 991-999.
18. Ghaleb MA, Barber N, Franklin BD, et al. Systematic Review of medication errors in pediatric patients. Ann Pharmacther, 2006, 40(10): 1766-1776.
19. 韓璐, 蘭瑛, 張伶俐, 等. 7例汶川地震擠壓綜合征患兒用藥分析. 中國循證醫學雜志, 2008, 8(9): 710-712.
20. 韓璐, 曾力楠, 張伶俐, 等. 329例汶川地震婦女兒童傷病員藥物利用分析. 中國循證醫學雜志, 2009, 9(3): 265-272.

《中國循證醫學雜志》

基于風險與責任，促進中國兒童合理用藥的思考

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

上一篇

下一篇

Format

Content

《中國循證醫學雜志》

基于風險與責任，促進中國兒童合理用藥的思考

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

上一篇

下一篇

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料